<VariationArchive RecordType="classified" VariationID="1805236" VariationName="NM_001197104.2(KMT2A):c.9195del (p.Ala3066fs)" VariationType="Deletion" Accession="VCV001805236" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1862250" VariationID="1805236">
      <GeneList>
        <Gene Symbol="KMT2A" FullName="lysine methyltransferase 2A" GeneID="4297" HGNC_ID="HGNC:7132" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118436492" stop="118526832" display_start="118436492" display_stop="118526832" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118307204" stop="118397538" display_start="118307204" display_stop="118397538" Strand="+" />
          </Location>
          <OMIM>159555</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001197104.2(KMT2A):c.9195del (p.Ala3066fs)</Name>
      <CanonicalSPDI>NC_000011.10:118505086:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118505087" stop="118505087" display_start="118505087" display_stop="118505087" variantLength="1" positionVCF="118505086" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118375802" stop="118375802" display_start="118375802" display_stop="118375802" variantLength="1" positionVCF="118375801" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>A3063fs</ProteinChange>
      <ProteinChange>A3066fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.118505087del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.118505087del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118375802del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118375802del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027813.1" sequenceAccession="NG_027813" sequenceVersion="1" change="g.73598del">
            <Expression>NG_027813.1:g.73598del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001197104.2" sequenceAccession="NM_001197104" sequenceVersion="2" change="c.9195del" MANESelect="true">
            <Expression>NM_001197104.2:c.9195del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001184033.1" sequenceAccession="NP_001184033" sequenceVersion="1" change="p.Ala3066fs">
            <Expression>NP_001184033.1:p.Ala3066fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001412597.1" sequenceAccession="NM_001412597" sequenceVersion="1" change="c.9285delA">
            <Expression>NM_001412597.1:c.9285delA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001399526.1" sequenceAccession="NP_001399526" sequenceVersion="1" change="p.Ala3096Leufs">
            <Expression>NP_001399526.1:p.Ala3096Leufs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005933.4" sequenceAccession="NM_005933" sequenceVersion="4" change="c.9186del">
            <Expression>NM_005933.4:c.9186del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005924.2" sequenceAccession="NP_005924" sequenceVersion="2" change="p.Ala3063fs">
            <Expression>NP_005924.2:p.Ala3063fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_613" sequenceAccession="LRG_613">
            <Expression>LRG_613:g.73598del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_613t1" sequenceAccession="LRG_613t1">
            <Expression>LRG_613t1:c.9195del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_613p1" sequenceAccession="LRG_613p1" change="p.Ala3066Leufs">
            <Expression>LRG_613p1:p.Ala3066Leufs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001197104.2(KMT2A):c.9195del (p.Ala3066fs) AND Wiedemann-Steiner syndrome" Accession="RCV002471654" Version="1">
        <ClassifiedConditionList TraitSetID="8851">
          <ClassifiedCondition DB="MedGen" ID="C1854630">Wiedemann-Steiner syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8851" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5217" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Wiedemann-Steiner syndrome</ElementValue>
                <XRef ID="MONDO:0011518" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Growth deficiency and mental retardation with facial dysmorphism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WDSTS</ElementValue>
                <XRef Type="MIM" ID="605130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5565" />
                <XRef ID="5565" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Wiedemann-Steiner syndrome (WSS) is characterized by developmental delay, intellectual disability, and characteristic facial features, with or without additional congenital anomalies. The facial features include thick eyebrows with lateral flare, vertically narrow and downslanted palpebral fissures, widely spaced eyes, long eyelashes, wide nasal bridge, broad nasal tip, thin vermilion of the upper lip, and thick scalp hair. About 60% of affected individuals have hypertrichosis cubiti ("hairy elbows"), which was once thought to be pathognomic for the syndrome, with a majority having hypertrichosis of other body parts. Other clinical features include feeding difficulties, prenatal and postnatal growth restriction, epilepsy, ophthalmologic anomalies, congenital heart defects, hand anomalies (such as brachydactyly and clinodactyly), hypotonia, vertebral anomalies (especially fusion anomalies of the cervical spine), renal and uterine anomalies, immune dysfunction, brain malformations, and dental anomalies.</Attribute>
                <XRef ID="NBK580718" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35617449</ID>
                <ID Source="BookShelf">NBK580718</ID>
              </Citation>
              <XRef ID="319182" DB="Orphanet" />
              <XRef ID="C1854630" DB="MedGen" />
              <XRef ID="MONDO:0011518" DB="MONDO" />
              <XRef Type="MIM" ID="605130" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5413383" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001197104_1_KMT2A_c_9195delA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002769097" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Wiedemann-Steiner syndrome (MIM#605130). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13021</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001197104.1:c.9195delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605130" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5413383" TraitType="Disease" MappingType="XRef" MappingValue="605130" MappingRef="OMIM">
        <MedGen CUI="C1854630" Name="Wiedemann-Steiner syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

